Recruiting: WA
Summary: PGx-ADAPT is a multi-phase study working with GPs and practice teams to co-design a practical and equitable approach to pharmacogenetics-guided antidepressant prescribing in Western Australian primary care.
The initial phase will explore practice staff knowledge, barriers and workflow needs, and gather feedback on a free GP-designed pharmacogenetics education module. Findings will inform a future implementation trial, including how this approach could work in rural and remote general practice
GP Requirements:
Practices can choose to take part in one or more activities:
-
A clinic-based focus group involving clinical and/or non-clinical practice staff, or individual staff interviews, to discuss current needs and practical considerations.
-
An expression of interest in the future practice-based implementation phase
-
Feedback on a free pharmacogenetics education module designed for GPs
GP/Participants recieve:
-
$250 reimbursement for each participant of a clinic-based
focus group or individual interview. -
An opportunity to shape a clinically useful model that
reflects the realities of everyday general practice. -
A certificate recognising completion of the education module
and participation in research activities, which may support CPD recording -
Free access to the GP-designed pharmacogenetics education
module.
Practices do not need to participate in the initial focus
groups or interviews to join the future implementation phase. Practices may
become involved at the phase that best suits their interests and capacity.